ARMCX3 and depressive symptom measurement: A growing number of studies have suggested that the nAChR is related to nicotine addiction, cognition, depression, hyperactivity disorder, cancer, and AD (Ma and Qian, 2019); therefore, ARMCX3 may promote the progression of AD.